The Study on Angiostatin/cisplatin As Treatment for Lewis Lung Cancer

周彩存,倪健,粟波,易祥华

DOI: https://doi.org/10.3781/j.issn.1000-7431.2004.04.019

2004-01-01

Tumor

Abstract:Objective To investigate the suppression of vascular endothelial proliferation and Lewis lung cacner growth by angiostatin/cisplatin.Methods Endothelial cells were seeded into 96 well plates and exposed to different agents for 72 hours and the number of the cell alive were counted with MTT.Lewis lung cancer cells were implanted into the skin of C57 mice and randomly divided into the 4 groups which were treated with different agents.Diameters of the mouse tumors were measured every other day.Twenty days later,the mice were killed and the tumor samples were isolated.The samples were examined pathologically and immunohistochemically.Results Cisplatin and angiostatin had a synergy in inhibition of endothelial cell proliferation.Tumor volumes,weights,and microvessel densities were less in cisplatin and cisplatin/angiostatin treated mice than in the control mice.Compared with cisplatin treated mice,tumor volumes and weights were smaller in cisplatin/ angiostatin treated mice( P 0.05 ).Conclusion Angiostatin and cisplatin could have synergic effects on endothelial proliferation and Lewis lung cancer growth.